KFF’s Chief Executive to Retire

Why It Matters

Altman's departure marks a generational shift at one of the most trusted health‑policy think tanks, potentially affecting the tone and continuity of data‑driven debate. Maintaining KFF’s neutral stance under new leadership is critical for policymakers, journalists and insurers relying on its analysis.

Key Takeaways

• Drew Altman retires after 36 years leading KFF.
• Larry Levitt becomes CEO; Mollyann Brodie appointed president.
• KFF stays neutral while covering contentious health policy topics.
• Organization shaped debate on ACA, vaccines, gender‑affirming care.
• Succession plan aims to preserve KFF’s research influence.

Pulse Analysis

Since its rebranding from the Kaiser Family Foundation, KFF has become a cornerstone of U.S. health‑policy intelligence. Under Drew Altman’s 36‑year stewardship, the organization expanded its data portals, launched the widely cited KFF Health Tracking Poll, and built a reputation for rigorous, nonpartisan analysis. This evolution helped KFF transition from a modest family foundation to a go‑to source for lawmakers, journalists, and insurers navigating complex reforms such as the Affordable Care Act and pandemic‑era vaccine distribution.

KFF’s commitment to neutrality distinguishes it in a crowded nonprofit landscape where many groups adopt advocacy positions. By presenting raw data and balanced briefs, KFF enables stakeholders to assess contentious topics—ranging from gender‑affirming care to Medicare payment reforms—without perceived bias. This approach has amplified its credibility, leading to frequent citations in congressional hearings and major media outlets. The organization’s ability to stay “in the eye of the storm” while maintaining objectivity has made its research indispensable for evidence‑based policymaking.

The upcoming leadership transition introduces Larry Levitt as chief executive and Mollyann Brodie as president, signaling continuity but also fresh strategic direction. Both executives have risen through KFF’s ranks, suggesting an internal succession that preserves institutional knowledge. Their challenge will be to sustain the organization’s neutral brand while adapting to emerging health crises, digital data demands, and heightened political scrutiny. If successful, KFF can continue shaping national health discourse and providing the reliable analytics that decision‑makers depend on.